A Study of PLX2853 in Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Auto Stem Cell Transplant for Lymphoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE2
Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide
- Status
- TERMINATED
- Phase
- N/A
Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
- Status
- COMPLETED
- Phase
- PHASE1
Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery
- Status
- COMPLETED
- Phase
- NA
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Status
- RECRUITING
- Phase
- PHASE1
A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow
- Status
- UNKNOWN
- Phase
- N/A
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
- Status
- COMPLETED
- Phase
- N/A
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
- Status
- WITHDRAWN
- Phase
- N/A
DS-3201b in Participants With Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1